logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 

Equities – Your destination to connect with the growth investment community.

IsoRay (ISR) Spikes Again on Announcement of Presentations at Weekend Conference

By  +Follow April 1, 2014 6:16AM
Share:
Tickers Mentioned:

Shares in small-cap health care company IsoRay (ISR) took off again on Tuesday after announcing plans to present five papers at the upcoming Annual Meeting of the American Brachytherapy Society (ABS).

"IsoRay is pleased to once again participate at the ABS annual meeting,” said CEO Dwight Babcock. “At this venue, thought leaders including Drs. Ron Benoit, Sushil Beriwal and Ryan P. Smith of the University of Pittsburg Medical Center (UPMC), Drs. Bhupesh Parashar and Gabriella Wernicke of Weill Cornell Medical College, and Dr. Brian Moran of the Chicago Prostate Center will be panelists or present their papers documenting their experiences and success in using our products.

IsoRay’s stock gapped up 17.3 percent to $2.58 a share with the opening bell and climbing to a high of $2.79 a share in choppy trading before pulling back to just under $2.60 by late morning. Shares were moving at a brisk clip, with over 17 million changing hands before noon against an average daily volume of just over 11.5 million.

The fact that the mere announcement of these presentations was enough to spike the stock like this would come as a surprise were it not for the wild March IsoRay just went through. The stock was trading at less than $1 a share until a March 14 article on Seeking Alpha prompted a boot to over $1.10 a share. However, it was five days later on March 19 when shares positively exploded following the announcement that IsoRay’s Cesium-131 brachytherapy had been used to effectively treat an aggressive form of cancer in a pediatric patient.

Since then, IsoRay has seen its volume skyrocket with big price swings on multiple days, including a pullback from 7-year highs after the announcement of a new public offering, then another rebound after the stock appeared to cross over into oversold territory.

The treatment driving IsoRay’s huge month is brachytherapy, or internal radiotherapy, using Cesium-131. It’s a method for radiation treatment of cancer that involves focused radiation through placing the radiation source, in IsoRay’s case a Cesium-131 seed mesh, into the human body surrounding the affected area.

However, beyond the science and fundamentals, it’s important to note that IsoRay appears to have become a popular momentum stock that’s closely watched by traders. Its average daily volume is more than 20 percent of its total float, and the stock’s heavy trading and incredible volatility is precisely what traders on the hunt for a quick play are looking for.

As such, the fact that the 14-day stochastic RSI for IsoRay’s stock had fallen below 0.20 is notable prior to the day’s surge. Stochastic RSI is popular with traders, and a level below 0.20 is traditionally viewed as oversold territory. And, while the 14-day RSI remains relatively high, it’s stayed under 70, the level above which stocks are traditionally viewed as being overbought, since its pull-back started on March 22.

So, with a news item to act as a catalyst and a buy signal from a key technical factor, it appears as though Wall Street’s favorite momentum play has struck again. Investors anticipating another big spike following the presentations at the conference, which takes place this weekend, could be trying to get in ahead of any new data that could be released, and it seems possible this action is getting buoyed by traders who, noting the stochastic RSI and the upward momentum, are jumping onto the big gains.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for ISR
x54389
6 May 15 22:43:07
$ISR YMB - Speculation - You have to wonder.... (short interest) http://t.co/C3uhMNakqP http://t.co/aHGfzUnRxr
x54389
6 May 15 22:26:01
$ISR YMB - Speculations on Babcock's plan (for IsoRay)? http://t.co/ieY5kO9tVv http://t.co/gY52CQpB7L
The Wolf
6 May 15 19:58:02
@Sandman7591 what day do they present? $ISR
The Wolf
6 May 15 19:50:14
@Ask_Diesel how long? 5$? $ISR
foolsgold
6 May 15 19:17:31
Watching 5/7 $AXN $CRNT $FPP $ISR $MM $NYMX $OIBR $PKD $SREV $TAS
DennyT
6 May 15 18:52:03
ISR IsoRay Inc. Market Cap Click Here -> http://t.co/lhGZGUYHe9 Trending $ISR $ASHR $RY $BIIB #ISR #nasdaq #investing
leahanne
6 May 15 18:50:05
GEVA Synageva BioPharma Corp. Bid Click Here -> http://t.co/WY8GqnTGRT Trending $GEVA $DBC $AGIO $ISR #GEVA #share #invest
Emylers
6 May 15 18:46:04
AGIO Agios Pharmaceuticals, Inc. Ex-Div Date Click Here -> http://t.co/vF68g2SHHX Trending $AGIO $DIA $UNG $ISR #AGIO #invest…
dailystockplays.com
6 May 15 14:42:12
Bullish Doji http://t.co/XRVBRB7QKq $LBTYA $JAH $PDLI $CLDN $GES $FCEL $SONS $DHI $SPLK $AMPE $GBSN $ATRS $VSI $ISR $GHDX $WCC $DMD $GOV
x54389
6 May 15 13:32:19
$ISR Isoray over 2X average volume for the day 1.86 Million shares vs. avg vol of 812 K. http://t.co/8arciSIw0y http://t.co/gnne86VOPT
x54389
6 May 15 12:36:18
$ISR $MRK -Speculation- Merck may buy Isoray as a moat for Keytruda if lung study is out&+ 5/8 http://t.co/YTangr59XC http://t.co/Me8yCxWYDs
x54389
6 May 15 12:29:55
$ISR $MRK -Isoray has FDA clearance for all solid tumor using Cesium-131 including SURFACE w/ known ratio sensitivity http://t.co/kgkWEYsOHs
•K|ndF|nance•
6 May 15 12:24:48
$ISR Adding to our 1.50s on the dips. #KindFinance
x54389
6 May 15 12:22:06
$ISR $MRK -Isoray has FDA clearance for all solid tumor using Cesium-131 including SURFACE w/ known ratio sensitivity http://t.co/i15r4ga8z0
•K|ndF|nance•
6 May 15 12:13:23
The #KindFinance team is loading $ISR. If you don't know why - find out. •••• #Stocks #Trading #Money $BRDT $GWPH $NVGN $GPRO $FB $TSLA
•K|ndF|nance•
6 May 15 12:11:13
RT @sentimentstock: $ISR Moving up on a Golden Cross. 50 day fast approaching the 200 day on the daily chart.
•K|ndF|nance•
6 May 15 12:11:05
RT @x54389: $ISR SPECULATION - If positive outcome w/ lung study5/8 we may see a 13D Filing by Soros $PTBI, Icahn $VLTC, et al. http://t.co…
•K|ndF|nance•
6 May 15 12:10:55
RT @x54389: $ISR $MRK Isoray Cesium-131 5/8 2:30PM Study ...implants resulted in no local recurrences and no radiation necrosis. http://t.c…
•K|ndF|nance•
6 May 15 12:10:39
RT @KendallTrade: $ISR $1.69 Estimated up to ~$3.25 may 8th...Cesium-131 Long Awaited Lung Study Results Appear To Be Coming May 8th
•K|ndF|nance•
6 May 15 12:10:26
RT @getmoney517365: $ISR no PR with the EOW event is strange. Buyout coming? Thoughts?
•K|ndF|nance•
6 May 15 12:10:13
RT @x54389: $ISR Brachytherapy market 2013 $680million projected to reach $2.4Billion in 2030. http://t.co/Sk8rdGcAKa http://t.co/LyNb…
Sentiment Stocks
6 May 15 10:54:30
$ISR Moving up on a Golden Cross. 50 day fast approaching the 200 day on the daily chart.
Ask Diesel
6 May 15 10:18:05
$ISR started long pos here
GoUrl Cryptocoin API
6 May 15 10:00:07
#Wordpress #Bitcoin Gateway! Vote Now - #Isracoin #ISR. Use FREE votes for $ISR! Goto - https://t.co/PNollGsjnV http://t.co/Ut8GyZDCdk
S Romberger
6 May 15 09:53:45
RT @AlertTrade: IsoRay Shares Move Higher; May be Attributed to Tweet: $ $ISR $ $MRK Isoray Cesium-131 5/8 2:30PM… http://t.co/112jRePXIA ~…
Frank
6 May 15 09:50:57
IsoRay Shares Move Higher; May be Attributed to Tweet: $ISR $MRK Isoray Cesium-131 5/8 2:30PM Study ...implants re… http://t.co/TU19XJs37m
Stock Trade Alerts
6 May 15 09:31:20
IsoRay Shares Move Higher; May be Attributed to Tweet: $ $ISR $ $MRK Isoray Cesium-131 5/8 2:30PM… http://t.co/112jRePXIA ~ via @AlertTrade
x54389
6 May 15 09:29:57
$ISR SPECULATION - If positive outcome w/ lung study5/8 we may see a 13D Filing by Soros $PTBI, Icahn $VLTC, et al. http://t.co/TH1VtcLUKH
TTN
6 May 15 09:25:52
@adamfeuerstein please help us understand > @x54389 $ISR $MRK Isoray Cesium-131 implants resulted in no local recurrences
Oasis of stocks
6 May 15 09:25:29
Flipped $ISR
KJS
6 May 15 09:24:36
$ISR push
Find Alpha
6 May 15 09:24:16
RT @x54389: $ISR $MRK Isoray Cesium-131 5/8 2:30PM Study ...implants resulted in no local recurrences and no radiation necrosis. http://t.c…
Blink
6 May 15 09:23:47
RT @x54389: $ISR $MRK Isoray Cesium-131 5/8 2:30PM Study ...implants resulted in no local recurrences and no radiation necrosis. http://t.c…
Large Void Bot
6 May 15 09:23:15
12:23 Pops: $ISR +3.5%
Brandon Hayward
6 May 15 09:21:15
$ISR volume...
x54389
6 May 15 09:01:38
$ISR $MRK Isoray Cesium-131 5/8 2:30PM Study ...implants resulted in no local recurrences and no radiation necrosis. http://t.co/KRAbc3oHjo
x54389
6 May 15 08:55:48
Commented on StockTwits: Fixed Link $MRK $ISR -SPECULATION– Merck may target Isoray given +equine outcome... http://t.co/7u5bhchVUk
Kendall Trade
6 May 15 08:49:20
$ISR great expectations with results next May 8.
Kendall Trade
6 May 15 08:47:33
$ISR The clinical trial was completed and investors have been patiently waiting and wondering when the results would be released May 8th
ThatStockGuy
6 May 15 08:46:18
SABBY if your out there, tks $ISR $GENE $PTBI just to name a few over the years. You guys rock!
Kendall Trade
6 May 15 08:45:41
$ISR http://t.co/aJgov4DoCD
x54389
6 May 15 08:45:30
$ISR 62,000 Shares bought in one minute at 11:40-11:41 AM http://t.co/1PpkdU6WCl
Kendall Trade
6 May 15 08:44:31
$ISR $1.69 Estimated up to ~$3.25 may 8th...Cesium-131 Long Awaited Lung Study Results Appear To Be Coming May 8th
Kendall Trade
6 May 15 08:43:07
$ISR Cesium-131 Long Awaited Lung Study Results Appear To Be Coming May 8th
x54389
6 May 15 08:15:42
$ISR - Speculation - Isoray has been quiet on all PR activity as to avoid unrelated noise prior to 5/8 3PM ET Lung Study results present.
x54389
6 May 15 08:13:18
$ISR - SPECULATION - Isoray published images on FB page for the benefit of mainstream media i.e. FT, WSJ, Reuters to use on 5/8
x54389
6 May 15 07:30:13
$ISR Brachytherapy market 2013 $680million projected to reach $2.4Billion in 2030. http://t.co/Sk8rdGcAKa http://t.co/LyNb48FsqA
BioInvestor
6 May 15 06:51:51
http://t.co/ApoDOQGwrb -therapeutics-present-breaking-poster-120300128.html AMI Data News $INCY $GILD $ISIS $tkmr $ISR $PFE $BLRX
Lorenzo Serra
6 May 15 05:19:41
If you are confused looking at $PTBI here are some past plays that had a similar run: $ISR $IPCI & $USU.
GetMoney (T2) (€$)
5 May 15 18:54:41
$ISR no PR with the EOW event is strange. Buyout coming? Thoughts?
				
				
By  +Follow April 1, 2014 6:16AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN